β3-adrenoceptors and other putative atypical β-adrenoceptors

Pharmacology Reviews and Communications

Volumn 9, Issue 1-2, 1997, Pages 141-148

  Arch, J R S ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

3 adrenoceptors; Adrenoceptors; Atypical adrenoceptors; BRL 37344; CGP 12177

Indexed keywords

EID: 26444525771     PISSN: 10288945     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. 3-adrenergic agonist, BRL 35135A, on glucose uptake in rat skeletal muscle in vivo and in vitro," Journal of Endocrinology, 139, 479-486.
2. Arch, J. R. S., Ainsworth, A. T., Cawthorne, M. A., Piercy, V., Sennitt, M. V., Thody, V. E., Wilson, C. and Wilson, S. (1984) "Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs," Nature, 309, 163-165.
3. Arch, J. R. S. (1989) "The brown adipocyte β-adrenoceptor," Proceedings of the Nutrition Society, 48, 215-223.
4. 3 and atypical β-adrenoceptors," Medical Research Reviews, 13, (6), 663-729.
5. 3-adrenoceptors in tissues," Pharmacology Communications, 6, 223-228.
6. 3-adrenoceptor agonists in the treatment of obesity and diabetes," International Journal of Obesity, 20, 191-199.
7. 3-Adrenoceptors and the regulation of metabolism in adipose tissues," Biochemistry Society Transactions, 24, 412-418.
8. 3-adrenoceptor mRNA in human tissues," European Journal of Pharmacology, 289, 223-228.
9. Boss, O. and Giacobino, J. (1996) "Characterisation of skeletal muscle β-adrenergic receptors," International Journal of Obesity, 20, Suppl. 4, 68.
10. Challis, R. A. J., Leighton, B., Wilson, S., Thurlby, P. L. and Arch, J. R. S. (1988) "An investigation of the β-adrenoceptor that mediates metabolic responses to the novel agonist BRL 28410 in rat soleus muscle," Biochemical Pharmacology, 37, 947-950.
11. 3-selective adrenoceptor antagonist SR 59230A," British Journal of Pharmacology, 117, 1374-1376.
12. 3-adrenergic receptor," Science, 245, 1118-1121.
13. 3-adrenoceptor: the search for a physiological function," Trends in Pharmacological Sciences, 15, 3-7.
14. 3-adrenoceptor mRNA in rat tissues," British Journal of Pharmacology, 117, 210-216.
15. 3-subtype," Obesity Research, 3, Suppl 3, 360s.
16. 3-adrenoceptors in the human heart," Journal of Clinical Investigation, 3, 556-562.
17. 3-Adrenergic Agonism (Futura Publishing Company: New York).
18. 3-adrenoceptor agonists on lipolysis in human omental adipocytes," International Journal of Obesity, 20, 428-434.
19. Huang, R-R. C., Yu, H., Strader, C. D. and Fong, T. M. (1994) "Interaction of substance P with the second and seventh transmembrane domains of the neurokinin-1 receptor," Biochemistry, 33, 3007-3013.
20. Kaumann, A. J. (1989) "Is there a third heart β-adrenoceptor?," Trends in Pharmacological Sciences, 10, 316-320.
21. Kaumann, A. J. (1996) "(-)-CGP 12177-induced increase of human atrial contraction through a putative third β-adrenoceptor," British Journal of Pharmacology, 117, 93-98.
22. Kaumann, A. J. and Lynham, J. A. (1996) "(-)CGP 12177 stimulates cyclic AMP-dependent protein kinase in rat atria through an atypical β-adrenoceptor," British Journal of Pharmacology (In Press)
23. 3-adrenoceptor in the rat," British Journal of Pharmacology, 118, 2085-2098.
24. 3-adrenergic receptor mRNA in man," Journal of Clinical Investigation, 91, 344-349.
25. Lafontan, M., Saulnier-Blache, J.-S., Carpene, C., Langin, D., Galitzky, J., Portillo, M., Larrouy, D. and Berlan, M. (1991) Fat cell adrenergic receptors: from molecular approaches to therapeutic strategies. in Obesity in Europe (ed. G. A. Ailhaud, et al) (John Libbey & Company Ltd.: London) pp. 141-153.
26. 3-adrenoceptor agonist in isolated rat proximal colon and white adipocytes," British Journal of Pharmacology, 114, 431P.
27. 3-adrenoceptor expression in white fat cells," Fundamentals of Clinical Pharmacology, 9, 97-106.
28. 3-adrenoceptor agonist (CL 316,243)," Drug Development Research, 32, 69-76.
29. 3-adrenoceptor agonist, BRL 35135, on tissue glucose utilisation," British Journal of Pharmacology, 114, 888-894.
30. Liu, Y-L., Cawthorne, M. A. and Stock, M. J. (1996a) "Biphasic effects of the β-adrenoceptor agonist, BRL 37344, on glucose utilization in rat isolated skeletal muscle," British Journal of Pharmacology, 117, 1355-1361.
31. 3-adrenoceptor," International Journal of Obesity, 20, Suppl 4, 73.
32. MacLaughlin, D. P. and MacDonald, A. (1991) "Characterization of catecholamine-mediated relaxations in rat isolated gastric fundus: evidence for an atypical β-adrenoceptor," British Journal of Pharmacology, 103, 1351-1356.
33. 3-adrenoceptors," British Journal of Pharmacology, 117, 943-949.
34. 3-selective antagonists, aryloxypropanolaminotetralins," British Journal of Pharmacology, 117, 435-442.
35. 3-adregenic agonist," Journal of Clinical Investigation, 97, 2898-2904.
36. 3-adregenic receptor antagonist in rat brown adipocytes," Molecular Pharmacology, 49, 7-14.
37. 3-adrenergic receptors," Fundamentals of Clinical Pharmacology, 9, 211-218.
38. 3-adrenergic agonists in isolated human fat cells from omental and retroperitoneal adipose tissues," Revista Espanola de Fisiologia, 51, 193-200.
39. 125I]-cyanopindolol binding sites in rat soleus muscle," British Journal of Pharmacology, 109, 344-352.
40. Roberts, S. J. (1996) Pharmacological characterisation of atypical β-adrenoceptors. PhD. Thesis. University of Melbourne.
41. Sarsero, D., Molenaar, P. and Kaumann, A. J. (1996) "The human cardiac atypical β-adrenoceptor stimulates a cyclic AMP-dependent pathway," Journal of Molecular and Cellular Cardiology, in press.
42. 3-AR. In: Genomes, molecular biology and drug discovery. (ed. M. J. Browne, et al) (Academic Press: London), p. 190.
43. 3-adrenoceptors compared in brown adipose tissue and in skeletal muscle membranes," British Journal of Pharmacology, 109, 1157-1163.
44. Tan, S. and Curtis Prior, P. B. (1983) "Characterization of the beta-adrenoceptor of the adipose cells of the rat," International Journal of Obesity, 7, 409-414.
45. 3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes," Journal Of Lipid Research, 37 (1), 87-97.
46. 3-adrenoceptor depends on receptor expression level and nature of the assay," (1996) Journal of Pharmacology and Experimental Therapeutics (In Press)